Eagle Wealth Advisors LLC

Position in LLY — ELI LILLY & Co

CIK 2107271 WESTPORT, CT

Position in LLY

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$1,315,774

-$16,052 QoQ

Shares Held

1,097

-24.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.30%

of 13F equity value

Holder Rank

#2,875

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Eagle Wealth Advisors LLC holds $3,436,635 across 6 Drug Manufacturers - General names. LLY ranks #1 (38.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,097	$1,315,774
2	AMGN	Amgen Inc	1,673	$605,826
3	JNJ	Johnson & Johnson	1,872	$475,431
4	GILD	Gilead Sciences, Inc.	3,619	$457,224
5	ABBV	AbbVie Inc.	1,315	$330,906
6	MRK	Merck & Co., Inc.	1,957	$251,474

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,315,774	1,097	-24.2%	Shares	Sole	2026-07-13
2026-03-31	$1,331,826	1,448	-35.8%	Shares	Sole	2026-04-23
2025-12-31	$2,424,478	2,256	—	Shares	Sole	2026-01-29
No filing history on record for this holder in this stock.